 

UUID:CD1F39BS-6CE4-430E-ABBc-A20432642E70
TcGA-LN-MSS—BlA-PR Redacted

IllllllllllllllIlllIlllllIIlllllllllllllllllll||||||||||||||
llll|||||l|||l||||II|||||||llllllllllllllllllllllll|l|||||||
|||||||||||llIlllllIlllllllllllllllllll|l|||l|||||||l| Tel: Fax,
Clinical Case Report
lob/o '3 (For Collection of Cancerous Tissue)

sz €411; “01 9” 79‘;
3.1a: twat/(3w new MM 6'5»;

[a ”Mir '
[Informed Consenﬂ

I personally informed this patient that a specimen(s) would be collected to be used for research
purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT
FORM with the patient and answered any questions the patient had. The patient then signed the
consent form as a free and voluntary act. A copy of this informed consent document will be retained at

 

 

 

 

 

 

 

 

 

 

 

 

 

 

our institution.
ﬂame of Physician or Study Coordinator Date
{Clinical Informationl
- GENERAL INFORMATION -
Date of Birth (mm/ddlwml . Height: Marital Status Race Temperature
b0“ :1»; El Single ”girlMarried ‘cmejw/M/Iﬂé’}?
Gender Weight D Divorced El Widow Blood Pressure Heart Rate
Wale El Female 6 97 {:91 L if f
a I ‘ U

 

HISTORY OF PRESENT ILLNESS

 

Chief Complaints: ﬁfoybbﬁz WWLU\'0\@3 Ucﬂcetﬂ aimingk

 

Symptoms: Mime/«9‘18 ] (£6024 ~

 

Clinical Findings:

 

Performance Scale (Karnofsky Score):
[3 100 Asymptomatic a 80-90 Symptomatic but Fully Ambulatory 60-70 Symptomatic, in bed less than 50% ofday

a 40-50 Symptomatic, in bed more than 50% ofday, but not (1 ridden B 20-30 Bed Ridden

 

 

 

CURRENT MEDICAT IONS
Dose

 

PAST MEDICAL HISTORY

 

 

 

 

 

OB/GYN HISTORY . >
Menopausal Status Date of First Menses # of Pregnancies
CI Pro-menopausal
El Peri-Menopausal Date of Last Menses # of Live Births

El Post-menopausal

 

 

 

 

Birth Control: Cl Condom El Oral Contraceptive

El Other:

DlUD

c1 Hormone Replacement
Therapy:

 

 

Current Status
El N0

Current
Cl YES NO

Current Status
:1 YES NO

SOCIAL HISTORY

Environmental Hazards:

Smoki H

Alcohol

FAMILY MEDICAL HISTORY"

Duration

Duration

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

- ' «v LAB DATA 2 .
Test Result l Date i Test Result Date
HIV BINgajive 0 Positive: [,1 CEA El Negative Cl Positive:

Hep B ngtive Cl Positive: ' . CA 15-3 El Negative Cl Positive:

Hep C é’Negative [3 Positive: CA 19-9 :1 NegitiZe a Positive:
AFP Cl Negative Cl Positive: PSA El Negative [3 Positive:

Other: D Negative [J Positive: Other: Ci Negative El Positive:

B/T Cell Markers:

 

 

DIAGNOSTIC STUDIES
Results

Ultrasound
X-Ra
CT

MRI
B

CLINICAL DIAGNOSIS

Distant

Date of
T N M Stage:

 

 

[Treatment Information!

SURGICAL TREATMENT
Date of Procedure

~

Prima Tumor
lied Location

a
Extension of Tumor

L Nodes
Location of l. Nodes
Palpable, Non—Dissected Lymph Nodes

Dissected Lymph Nodes

Distant Metastasis
Detailed Location

Su ical
T N M

NEOADJUVENT THERAPY or Molecular

reatment Date
/

 

 

Pathology Form

 

{Specimen Informatioﬂ

 

 

 

 

 

 

 

 

 

 

 

 

Collected by: __ - Date: _I‘ime:_
Preserved by: , _ Date: Time;
SPECIMEN TYPE (# of samples provided) -
Frozen Parafﬁn Block Blood/Serumli’lasma Slide
Diseased Normal Diseased Normal Diseased Normal Diseased Normal
3 1 3 2 3 5?—
Tlme to LN2 Time to Formalin Time to LNZ ~ ..
4’0 min 1‘] min min ‘ ‘

 

 

PATHOLOGICAL DESCRIPTION

Pri Tumor
Size Extension of Tumor Distance to NAT

X cm ’6 cm

WWW L Nodes

Location # Examined # Metastasized

Distant Metastasis

Location

Pathol ical
pT N0 M (9

Notes:

 

 

 

[Microscopic Description!

Histo Pattern
Cell Distribution + - Pattern
Diffuse
Mosaic Storlfonn
Fibrosis
L Inﬁltration Pa
Vascular Invasion
Clusterized

Indian
Cellular Differentiation '

+ - Adenomatous + - Sarcomatous + - L
Cell cell
Cell Cell Stratiﬁcation Fibroblast Small Cell
Osteoblast R5 R5 Like
Desmosome Vacuole Inflam. Cell
Pearl Gland formation Plasma Cell

Cellular Differentiation: Well El Moderate [1 Poor

Nuclear
Nuclear 0 II

Prominent
Giant Cell

Nuclear Grade:

IHC Data .

Marker
a Positive

:1 Positive
0 Positive
:3 Positive
El Positive
D Positive
El Positive

PR
Her- neu
B—Cell Marker
T-Cell Marker

0000000
2

Other:

 

 

[Final Pathology Repord

 

 

 

 

 

 

 

Histological Diagnosis: 30,; A m/ 959 CM (aﬂr/WMJ 91. 7%(5 C” 813 0/947/{3’
/ 4:11?” (/ﬂﬁéﬂFn/aﬁ/ég/ ) [10 /)/V/)ﬂ’/o/ Grade:/,L. “U
J7
Comments: I
— Pathologist Date

. CONSOLIDATED DIAGNOSTIC PATHOLOGY FORM“ '
Microscopic Appearance:

1.

DISTRI

2. Cellular

Cell Cell

V
Pearl Gland fonnation Plasma Cell

Otherwise D 73 b

2. Cellular DI exudation: ‘ J

Well chnlely Pom
’ /'

 

 

 

 

 

 

 

 

 

 

:jggmmmr @MW,6~L'

 

Histological DiagnOSiS
Comment-'3'
”'63s:
rorrmomos BYW‘MD

 

